Sheri A Poznanovic1, Stephen P Cass, Brian D Kavanagh. 1. Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine, 4200 E. 9th Avenue, Box B-205, Denver, CO 80262, USA. sheripoz@yahoo.com
Abstract
OBJECTIVE: Glomus jugulare tumors (GJT) have traditionally been treated by surgery or fractionated external beam radiation therapy (XRT). This study evaluates acute toxicity and short-term efficacy of single-fraction stereotactic radiosurgery (SRS) for the treatment of GJT. STUDY DESIGN AND SETTING: Eight patients (age range 28-74) with GJT underwent SRS (Brainlab linear accelerator) as primary treatment. A nominal dose of 15-16 Gy was prescribed. RESULTS: After undergoing SRS, 7 of 8 patients (87.5%) reported complete resolution of presenting symptoms. Follow-up MRIs showed tumor stabilization in 100% of patients. Transient vertigo occurred in one patient. One patient suffered acute GI upset and transient lower cranial neuropathy. CONCLUSION: Stereotactic radiosurgery is an effective alternative for patients with GJT in achieving tumor control and resolution of symptoms. EBM RATING: C-4.
OBJECTIVE:Glomus jugulare tumors (GJT) have traditionally been treated by surgery or fractionated external beam radiation therapy (XRT). This study evaluates acute toxicity and short-term efficacy of single-fraction stereotactic radiosurgery (SRS) for the treatment of GJT. STUDY DESIGN AND SETTING: Eight patients (age range 28-74) with GJT underwent SRS (Brainlab linear accelerator) as primary treatment. A nominal dose of 15-16 Gy was prescribed. RESULTS: After undergoing SRS, 7 of 8 patients (87.5%) reported complete resolution of presenting symptoms. Follow-up MRIs showed tumor stabilization in 100% of patients. Transient vertigo occurred in one patient. One patient suffered acute GI upset and transient lower cranial neuropathy. CONCLUSION: Stereotactic radiosurgery is an effective alternative for patients with GJT in achieving tumor control and resolution of symptoms. EBM RATING: C-4.
Authors: David Taïeb; Alexandre Kaliski; Carsten C Boedeker; Victoria Martucci; Tito Fojo; John R Adler; Karel Pacak Journal: Endocr Rev Date: 2014-07-17 Impact factor: 19.871
Authors: Zachary D Guss; Sachin Batra; Charles J Limb; Gordon Li; Michael E Sughrue; Kristin Redmond; Daniele Rigamonti; Andrew T Parsa; Steven Chang; Lawrence Kleinberg; Michael Lim Journal: Int J Radiat Oncol Biol Phys Date: 2011-06-22 Impact factor: 7.038
Authors: Faycal El Majdoub; Stefan Hunsche; Alhadi Igressa; Martin Kocher; Volker Sturm; Mohammad Maarouf Journal: PLoS One Date: 2015-06-12 Impact factor: 3.240
Authors: Emerson Magno de Andrade; José Reginaldo Brito; Susana Dias Mario; Suely Maymone de Melo; Salomon Benabou Journal: Surg Neurol Int Date: 2013-11-20